Publication:
The threat of antimalarial drug resistance

dc.contributor.authorBorimas Hanboonkunupakarnen_US
dc.contributor.authorNicholas J. Whiteen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherNuffield Department of Clinical Medicineen_US
dc.date.accessioned2018-11-23T11:03:20Z
dc.date.available2018-11-23T11:03:20Z
dc.date.issued2015-01-01en_US
dc.description.abstract© 2016 The Author(s). The battle between man and malaria has continued for thousands of years. Antimalarial drugs are essential weapons to fight the disease, but their efficacy is threatened by drug resistance which continues to emerge creating a major obstacle to malaria control and jeopardizing renewed hopes for elimination. As 2016 is the first year under WHO Global Technical Strategy for Malaria 2016-2030, it is a good time to ponder the progress of both sides and plan for the future.en_US
dc.identifier.citationTropical Diseases, Travel Medicine and Vaccines. Vol.2, No.1 (2015), 1-5en_US
dc.identifier.doi10.1186/s40794-016-0027-8en_US
dc.identifier.issn20550936en_US
dc.identifier.other2-s2.0-85026375463en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/36767
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85026375463&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleThe threat of antimalarial drug resistanceen_US
dc.typeReviewen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85026375463&origin=inwarden_US

Files

Collections